Biomarkers for Diabetes

"Biomarker", are designated "molecular marker" or a "signature particle". These markers gives the degree of illness as they lay outside calmly. HbA1c is considered a biomarker for a risk factor that is for retinopathy, nephropathy and other vascular sicknesses. Biomarkers empower preventive measures to be connected at the subclinical stage and the reactions to preventive or helpful measures to be observed. Cases in the course of recent decades have yielded test sets, for the most part blood products and urine from an expansive classification of patients with both type 1 and type 2 diabetes.

  • Carbonyl stress
  • Pulse wave analysis
  • Auto fluorescence
  • Biomarkers of vascular function in diabetes

Related Conference of Biomarkers for Diabetes

November 11-12, 2019

Annual Congress on Diabetes, Metabolism and Obesity

Sydney, Australia
Diabetes Congress 2019 | December 04-05, 2019 |

3rd Annual Congress on Diabetes and Its Complications

Tokyo, Japan
December 9,10,2019

International Congress and Expo on Diabetic Care

Bangkok,Thailand
December 12-13, 2019

Annual Congress on Diabetes and Endocrinology

Dubai, UAE
January 29-30, 2020

Global Summit On Diabetes & Endocrinology

Bangkok, Thailand
March 25-26, 2020

29th World Diabetes & Heart Congress

| Radisson Narita | Tokyo, Japan
March 27-28, 2020

Annual Summit on Metabolomics

Amsterdam, Netherlands
April 15-16 2020

14th European Diabetes and Endocrinology Congress

| Barcelona, Spain
April 20-21, 2020

2nd Global Meeting on Diabetes and Endocrinology

Amsterdam, Netherlands
June 15-16, 2020

29thEuropean Diabetes Congress

| Barcelona, Spain
June 14-15, 2021

diabetic 2021

Abu Dhabi, UAE

Biomarkers for Diabetes Conference Speakers

Recommended Sessions

Related Journals

Are you interested in